Journal articles on the topic 'Nottingham Prognostic Index (NPI)'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Nottingham Prognostic Index (NPI).'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Akhtar, Zahid Mahmood, Rabia Altaf, Muhammad Shahbaz Amin, and Seema Butt. "Relationship of Nottingham Prognostic Index with prognostic parameters of breast carcinoma." Pakistan Journal of Medical and Health Sciences 16, no. 6 (June 22, 2022): 26–28. http://dx.doi.org/10.53350/pjmhs2216626.
Full textBall, G., C. Lemetre, A. R. Green, I. O. Ellis, and R. Blamey. "O-72 Remodeling the Nottingham Prognostic Index (NPI) for individual prognosis." European Journal of Cancer Supplements 8, no. 6 (September 2010): 27–28. http://dx.doi.org/10.1016/j.ejcsup.2010.06.073.
Full textVan Belle, V., J. Decock, W. Hendrickx, O. Brouckaert, S. Pintens, P. Moerman, H. Wildiers, et al. "Short-Term Prognostic Index for Breast Cancer: NPI or Lpi." Pathology Research International 2011 (December 28, 2011): 1–7. http://dx.doi.org/10.4061/2011/918408.
Full textMorgan, D. A. L., D. M. Sibbering, M. Galea, I. O. Ellis, C. W. Elston, and R. W. Blamey. "Selection for adjuvant systemic therapy using the Nottingham prognostic index (NPI)." Breast 2, no. 3 (September 1993): 206. http://dx.doi.org/10.1016/0960-9776(93)90146-7.
Full textShukla, Ashish, S. C. Jain, and Manish Swarnkar. "Correlation of axillary lymph nodes involvement and Nottingham prognostic index with various histopathologic prognostic factors in invasive breast carcinoma." International Surgery Journal 6, no. 4 (March 26, 2019): 1187. http://dx.doi.org/10.18203/2349-2902.isj20191055.
Full textWegscheider, Anne-Sophie, Bernhard Ulm, Kay Friedrichs, Christoph Lindner Lindner, and Axel Niendorf. "Altona Prognostic Index: A New Prognostic Index for ER-Positive and Her2-Negative Breast Cancer of No Special Type." Cancers 13, no. 15 (July 28, 2021): 3799. http://dx.doi.org/10.3390/cancers13153799.
Full textThangjam, D., S. K. Agrawal, S. Chatterjee, and R. Ahmed. "Nottingham Prognostic index (NPI) – a Simple Predictive Tool for Operable Breast Cancer." Clinical Oncology 29, no. 3 (March 2017): e75. http://dx.doi.org/10.1016/j.clon.2016.10.017.
Full textFong, Y., J. Evans, D. Brook, J. Kenkre, P. Jarvis, and K. Gower-Thomas. "The Nottingham Prognostic Index: five- and ten-year data for all-cause Survival within a Screened Population." Annals of The Royal College of Surgeons of England 97, no. 2 (March 2015): 137–39. http://dx.doi.org/10.1308/003588414x14055925060514.
Full textZhou, Li, Maria Rueda, and Abedalrhman Alkhateeb. "Classification of Breast Cancer Nottingham Prognostic Index Using High-Dimensional Embedding and Residual Neural Network." Cancers 14, no. 4 (February 13, 2022): 934. http://dx.doi.org/10.3390/cancers14040934.
Full textHasby, Eiman Adel, and Rana Adel Khalifa. "Expression of CD74 in Invasive Breast Carcinoma: Its Relation to Nottingham Prognostic Index, Hormone Receptors, and HER2 Immunoprofile." Tumori Journal 103, no. 2 (February 11, 2016): 193–203. http://dx.doi.org/10.5301/tj.5000562.
Full textPradhan, A., P. Paudyal, AK Sinha, and CS Agrawal. "Grading, staging and Nottingham prognostic index scoring of breast carcinoma." Journal of Pathology of Nepal 7, no. 1 (March 30, 2017): 1078–83. http://dx.doi.org/10.3126/jpn.v7i1.16951.
Full textVan Belle, Vanya, Ben Van Calster, Olivier Brouckaert, Isabelle Vanden Bempt, Saskia Pintens, Vernon Harvey, Paula Murray, et al. "Qualitative Assessment of the Progesterone Receptor and HER2 Improves the Nottingham Prognostic Index Up to 5 Years After Breast Cancer Diagnosis." Journal of Clinical Oncology 28, no. 27 (September 20, 2010): 4129–34. http://dx.doi.org/10.1200/jco.2009.26.4200.
Full textMalmström, P., P.-O. Bendahl, P. Boiesen, N. Brünner, I. Idvall, and M. Fernö. "S-Phase Fraction and Urokinase Plasminogen Activator Are Better Markers for Distant Recurrences Than Nottingham Prognostic Index and Histologic Grade in a Prospective Study of Premenopausal Lymph Node–Negative Breast Cancer." Journal of Clinical Oncology 19, no. 7 (April 1, 2001): 2010–19. http://dx.doi.org/10.1200/jco.2001.19.7.2010.
Full textRakha, E. A., D. Soria, A. R. Green, C. Lemetre, D. G. Powe, C. C. Nolan, J. M. Garibaldi, G. Ball, and I. O. Ellis. "Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer." British Journal of Cancer 110, no. 7 (March 11, 2014): 1688–97. http://dx.doi.org/10.1038/bjc.2014.120.
Full textHolli, K., R. W. Blarney, G. R. Ball, I. O. Ellis, and S. Pinder. "External validation in ONCOPOOL of updated survival according to the Nottingham Prognostic Index (NPI)." European Journal of Cancer Supplements 6, no. 7 (April 2008): 186–87. http://dx.doi.org/10.1016/s1359-6349(08)70776-6.
Full textGreen, Andrew R., D. Soria, D. G. Powe, C. C. Nolan, M. Aleskandarany, M. A. Szász, A. M. Tőkés, et al. "Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer." Breast Cancer Research and Treatment 157, no. 1 (April 26, 2016): 65–75. http://dx.doi.org/10.1007/s10549-016-3804-1.
Full textO'Connor, Darran, Catherine Margaret Kelly, John Crown, Niamh Russell, Stephen Barron, Tony Loughman, Seodhna Lynch, et al. "Additional prognostic value of OncoMasTR multigene prognostic signature to clinicopathological information in patients with HR-positive, HER2-negative, lymph node-negative breast cancer from the TAILORx Tissue Bank, Ireland." Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 535. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.535.
Full textRizki, Hirah, Christopher Hillyar, Omar Abbassi, Gillian Clayton, Sascha Dua, Tasha Gandamihardja, and Simon Smith. "P091. Oncotype DX, Predict, and the Nottingham Prognostic Index (NPI) – A study in decision making." European Journal of Surgical Oncology 45, no. 5 (May 2019): 909. http://dx.doi.org/10.1016/j.ejso.2019.01.113.
Full textNesrine, M., H. El Benna, Y. Berrazegua, S. Labidi, N. Daoud, and H. Boussen. "Significance of receptors expression, mitotic index and Ki67 in breast cancer patients with Nottingham Prognostic Index (NPI) poor prognosis score." Annals of Oncology 29 (October 2018): viii69. http://dx.doi.org/10.1093/annonc/mdy270.211.
Full textGonzalez, Michael A., Sarah E. Pinder, Grace Callagy, Sarah L. Vowler, Lesley S. Morris, Kate Bird, Jane A. Bell, Ronald A. Laskey, and Nicholas Coleman. "Minichromosome Maintenance Protein 2 Is a Strong Independent Prognostic Marker in Breast Cancer." Journal of Clinical Oncology 21, no. 23 (December 1, 2003): 4306–13. http://dx.doi.org/10.1200/jco.2003.04.121.
Full textCuperjani, Frederik, Lumturije Gashi, Fisnik Kurshumliu, Shemsedin Dreshaj, and Fitim Selimi. "Relationship between Ribosomal Protein S6-pS240 Expression and other Prognostic Factors in Non-Special Type Invasive Breast Cancer." Breast Care 14, no. 3 (November 14, 2018): 171–75. http://dx.doi.org/10.1159/000491427.
Full textAbrial, C., X. Durando, P. Chollet, O. Tacca, I. Raoelfils, M. Mouret-Reynier, P. Gimbergues, and F. Penault-Llorca. "Comparison between two prognostic index: Nottingham index (NPI) and an alternative index based on log of nodal involvement (Lpi)." Journal of Clinical Oncology 26, no. 15_suppl (May 20, 2008): 22146. http://dx.doi.org/10.1200/jco.2008.26.15_suppl.22146.
Full textHolli, K., R. W. Blamey, M. J. Mitchell, M. Blichert-Toft, L. Cataliotti, I. O. Ellis, A. Fourquet, et al. "O-62 External validation in ONCOPOOL of updated survival according to the Nottingham Prognostic Index (NPI)." European Journal of Cancer Supplements 5, no. 3 (September 2007): 19. http://dx.doi.org/10.1016/s1359-6349(07)71752-4.
Full textGreen, Andrew R., D. Soria, D. G. Powe, C. C. Nolan, M. Aleskandarany, M. A. Szász, A. M. Tőkés, et al. "Erratum to: Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer." Breast Cancer Research and Treatment 159, no. 1 (July 22, 2016): 199. http://dx.doi.org/10.1007/s10549-016-3907-8.
Full textMalami, S. A., and S. M. Sahabi. "Relevance of modified prognostic score for breast carcinoma on fine needle aspiration cytology in a resource-poor setting." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 21177. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.21177.
Full textQuintyne, Keith Ian, Bernie Woulfe, and Rajnish K. Gupta. "Correlation between 21-gene recurrence score assay with Nottingham prognostic index (NPI) and Adjuvant! Online (AO) prognostic tools in newly diagnosed patients with early-stage breast cancer in midwestern Ireland." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e16551-e16551. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e16551.
Full textAgnani, Bhawna, Ranjana Solanki, Maryem Ansari, and Sankalp Agnani. "Prognostic Significance of Microvessel Density as Assessed by anti CD34 Monoclonal Antibody in Invasive Ductal Carcinoma of Breast." Asian Pacific Journal of Cancer Biology 5, no. 3 (September 15, 2020): 75–79. http://dx.doi.org/10.31557/apjcb.2020.5.3.75-79.
Full textElwood, M., S. Tin Tin, E. Tawfiq, R. J. Marshall, T. M. Phung, R. Lawrenson, I. Campbell, and V. Harvey. "A New Predictive Model for Breast Cancer Survival in New Zealand: Development, Internal and External Validation, and Comparison With the Nottingham Prognostic Index." Journal of Global Oncology 4, Supplement 2 (October 1, 2018): 227s. http://dx.doi.org/10.1200/jgo.18.91800.
Full textGallagher, Emily, Derek Leroith, Sheldon M. Feldman, Elisa R. Port, Neil B. Friedman, Susan K. Boolbol, Brigid K. Killelea, et al. "Are racial differences in obesity and insulin resistance related to aggressive breast cancer?" Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): e18157-e18157. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e18157.
Full textAgrawal, S., D. Thangjam, and A. Rosina. "Nottingham Prognostic index (NPI) − a simple predictive tool for operable breast cancer − utility in non screened cohort." European Journal of Cancer 72 (February 2017): S14. http://dx.doi.org/10.1016/s0959-8049(17)30125-9.
Full textCampone, M., C. Charbonnel, F. Magrangeas, S. Minvielle, J. Genève, A. Martin, R. Deporte, R. Bataille, L. Campion, and P. Jézéquel. "Establishment of a predictive classifier of node-positive breast cancer patients treated by FEC100 chemotherapy using gene expression profiling." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 13004. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.13004.
Full textWen, Jiahuai, Feng Ye, Shuaijie Li, Xiaojia Huang, Lu Yang, Xiangsheng Xiao, and Xiaoming Xie. "The Practicability of a Novel Prognostic Index (PI) Model and Comparison with Nottingham Prognostic Index (NPI) in Stage I–III Breast Cancer Patients Undergoing Surgical Treatment." PLOS ONE 10, no. 11 (November 23, 2015): e0143537. http://dx.doi.org/10.1371/journal.pone.0143537.
Full textGreen, N., A. Al-Allak, and C. Fowler. "Benefits of introduction of Oncotype DX® testing." Annals of The Royal College of Surgeons of England 101, no. 1 (January 2019): 55–59. http://dx.doi.org/10.1308/rcsann.2018.0173.
Full textLiu, Ming, Shao-Xian Tang, Julia Y. S. Tsang, Yu-Jie Shi, Yun-Bi Ni, Bonita K. B. Law, and Gary M. K. Tse. "Core needle biopsy as an alternative to whole section in IHC4 score assessment for breast cancer prognostication." Journal of Clinical Pathology 71, no. 12 (September 18, 2018): 1084–89. http://dx.doi.org/10.1136/jclinpath-2018-205228.
Full textBlamey, R., H. G. Bishop, G. M. Lawrence, S. Pinder, R. Wilson, and A. Evans. "The prognoses of tumours detected in the UK breast screening programme (NHS BSP) analysed by the Nottingham Prognostic Index (NPI)." European Journal of Cancer Supplements 2, no. 3 (March 2004): 180. http://dx.doi.org/10.1016/s1359-6349(04)91031-2.
Full textXiang, Yan, Li Li, Mark Zarella, Katarzyna Brzezinska, Kareem Hosny, Steve Hou, and Fernando Garcia. "B-Cell lymphoma 2 Protein Expression and Established Clinicopathologic Features in Breast Cancers." American Journal of Clinical Pathology 152, Supplement_1 (September 11, 2019): S51. http://dx.doi.org/10.1093/ajcp/aqz113.035.
Full textEgorov, M. V., V. E. Sinitsyn, and A. V. Bakunovich. "Magnetic Resonance Spectroscopy in the Diagnosis and Prognosis of Breast Cancer." Journal of radiology and nuclear medicine 100, no. 5 (November 4, 2019): 293–97. http://dx.doi.org/10.20862/0042-4676-2019-100-5-293-297.
Full textKumari, Priyanka, Sumit Bhaskar, Rajiv Ranjan, and Dipendra Kumar Sinha. "Incidence of triple negative breast cancer at Rajendra Institute of Medical Sciences, Ranchi." International Surgery Journal 6, no. 9 (August 28, 2019): 3134. http://dx.doi.org/10.18203/2349-2902.isj20194045.
Full textIftikhar, Muhammad Adil, Khalil Ahmed, Usman Ali Rahman, Malihajavaid Butt, Iftikhar Ahmed, and M. Kaleem Akhtar. "Recurrence Rate of Carcinoma Breast patients Undergoing Mastectomy at Gulab Devi Hospital Lahore." Pakistan Journal of Medical and Health Sciences 15, no. 7 (July 26, 2021): 1464–66. http://dx.doi.org/10.53350/pjmhs211571464.
Full textTsang, Yuk-Wah, Chi-Hsun Liao, Chiao-Hsu Ke, Chi-Wen Tu, and Chen-Si Lin. "Integrated Molecular Characterization to Reveal the Association between Kynurenine 3-Monooxygenase Expression and Tumorigenesis in Human Breast Cancers." Journal of Personalized Medicine 11, no. 10 (September 24, 2021): 948. http://dx.doi.org/10.3390/jpm11100948.
Full textGiltnane, J. M., J. Rapp, C. Moeder, R. L. Camp, H. Kluger, A. Molinaro, and D. Rimm. "Construction of a five-marker protein-based model for stage-independent assessment of prognosis in breast cancer." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): 11013. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.11013.
Full textLi, Qin, Li Li, Xiaoyue Jiang, Qi Du, Yingrui Li, Teng Li, Hong Gong, and Bangwei Cao. "Characteristics and prognostic values of traditional pathological parameters and advanced molecular subtypes in women in Beijing with operable breast cancer: a retrospective analysis." BMJ Open 8, no. 11 (November 2018): e021819. http://dx.doi.org/10.1136/bmjopen-2018-021819.
Full textShatnawi, Aymen, Nehad M. Ayoub, Amer E. Alkhalifa, and Dalia R. Ibrahim. "Estrogen-Related Receptors Gene Expression and Copy Number Alteration Association With the Clinicopathologic Characteristics of Breast Cancer." Breast Cancer: Basic and Clinical Research 16 (January 2022): 117822342210867. http://dx.doi.org/10.1177/11782234221086713.
Full textAhmed, Nagwa Abd El-Sadek, and Maisa Hashem Mohammed. "Significance of CD133 Expression in Invasive Ductal Carcinoma of the Breast." Asian Pacific Journal of Cancer Biology 7, no. 1 (February 23, 2022): 9–14. http://dx.doi.org/10.31557/apjcb.2022.7.1.9-14.
Full textWang, Tian, Ting Zhou, Fangfang Fu, Yingyan Han, Yan Li, and Ming Yuan. "HMGA1 As a Potential Prognostic and Therapeutic Biomarker in Breast Cancer." Disease Markers 2022 (November 26, 2022): 1–12. http://dx.doi.org/10.1155/2022/7466555.
Full textQuintyne, K. I., B. Woulfe, and R. K. Gupta. "Retrospective application of Nottingham Prognostic Index (NPI) and Adjuvant! Online tool in newly diagnosed patients with early breast cancer in mid-western Ireland." Journal of Clinical Oncology 28, no. 15_suppl (May 20, 2010): 6139. http://dx.doi.org/10.1200/jco.2010.28.15_suppl.6139.
Full textVallejo, C. T., J. A. Lacava, P. M. Cabaleiro, P. Butín, M. Cari, S. E. Albornoz, J. R. Castro, A. Novoa, M. Mac Donnell, and B. A. Leone. "The Nottingham Prognostic Index (NPI) applied to 467 patients (pts) with a long-term follow-up that were treated in a single institution." Journal of Clinical Oncology 22, no. 14_suppl (July 15, 2004): 9657. http://dx.doi.org/10.1200/jco.2004.22.90140.9657.
Full textVallejo, C. T., J. A. Lacava, P. M. Cabaleiro, P. Butín, M. Cari, S. E. Albornoz, J. R. Castro, A. Novoa, M. Mac Donnell, and B. A. Leone. "The Nottingham Prognostic Index (NPI) applied to 467 patients (pts) with a long-term follow-up that were treated in a single institution." Journal of Clinical Oncology 22, no. 14_suppl (July 15, 2004): 9657. http://dx.doi.org/10.1200/jco.2004.22.14_suppl.9657.
Full textJasar, Dzengis N., Katerina B. Kubelka-Sabit, and Vanja A. Filipovski. "Impact of the nottingham prognostic index (NPI) on the occurrence of relapses compared with the HER-2/neu expression in breast cancer patients." Pathology 46 (2014): S57. http://dx.doi.org/10.1097/01.pat.0000454295.14782.1f.
Full textMane, Vaibhav, Nekta Anand, and Darshana Wakkar. "Correlation ER/PR status of Breast Carcinoma with Tumor size, Tumor grade, Lymphovascular emboli, Lymph node metastasis and the distant metastasis." IP Archives of Cytology and Histopathology Research 6, no. 3 (September 15, 2021): 191–96. http://dx.doi.org/10.18231/j.achr.2021.043.
Full text